Immunochina Pharmaceuticals
Immunochina provides cancer diagnosis and treatment services based on Chimeric Antigen Receptor T-cell immunotherapy.
All edits
Edits on 6 Jan, 2024
Golden Au
Edits made to:
Infobox (+3 properties)
Infobox
Edits on 6 Apr, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 20 Sep, 2022
Golden AI
Edits on 13 Jul, 2022
Bhupendra Solanki
Edits made to:
Infobox (+1 properties)
Infobox
Company Operating Status
Active
Bhupendra Solanki
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 10 Jun, 2022
Golden AI
Edits on 15 Mar, 2022
Golden AI
Edits on 16 Feb, 2022
Keeri Tramm
Edits made to:
Infobox (+4 properties)
Description (+117 characters)
Immunochina Pharmaceuticals
Immunochina provides cancer diagnosis and treatment services based on Chimeric Antigen Receptor T-cell immunotherapy.
Infobox
Edits on 12 May, 2021
Golden AI
Edits on 28 Mar, 2021
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Edits on 6 Oct, 2020
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
January 2019
Edits on 26 Mar, 2020
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
20,400,000
Edits on 30 Jul, 2019
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Edits on 25 Jul, 2019
Neelam Jhaveri
Edits made to:
Infobox (+4 properties)
Immunochina Pharmaceuticals
Immunochina provides cancer diagnosis and treatment services based on Chimeric Antigen Receptor T-cell immunotherapy.
Infobox
Neelam Jhaveri
Edits made to:
Immunochina Pharmaceuticals
Immunochina provides cancer diagnosis and treatment services based on Chimeric Antigen Receptor T-cell immunotherapy.
Find more companies like Immunochina Pharmaceuticals
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
